Ignite Creation Date:
2024-05-05 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00476151
Status:
COMPLETED
Last Update Posted:
2011-05-17
First Post:
2007-05-17
Brief Title:
A Study of the Efficacy and Safety of AmitriptylineKetamine Topical Cream in Patients With Diabetic Peripheral Neuropathy
Sponsor:
EpiCept Corporation
Organization:
EpiCept Corporation
Study Overview
Official Title:
A Multicenter Double-Blind Randomized Placebo-Controlled Study of the Efficacy and Safety of EpiCept NP-1 Topical Cream in Patients With Pain From Diabetic Peripheral Neuropathy DPN
Status:
COMPLETED
Status Verified Date:
2011-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a multicenter randomized placebo-controlled parallel group study of EpiCept NP-1 Topical Cream amitriptyline 4ketamine 2 in approximately 200 patients with pain in the lower extremities due to diabetic nerve pain
Detailed Description:
This is a phase II multicenter randomized placebo-controlled parallel group study of EpiCept NP-1 Topical Cream amitriptyline 4ketamine 2 in approximately 200 patients with chronic pain in the lower extremities due to diabetic peripheral neuropathy DPN
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None